MobileSmith Health announced the appointment of Dr. Jay Steinberg as clinical advisor. As a Board-Certified Cardiothoracic Surgeon for over 15 years, Steinberg brings with him a background in designing and implementing health programs in large health systems throughout the Northeast U.S. where engagement with clinical, administrative and support services were critical to ensuring success. In his role as clinical advisor, Steinberg will help address these challenges by offering guidance based on first-hand clinical experience that will impact perioperative program product integration and mitigating barriers to entry for hospitals. Dr. Steinberg currently serves on the Scientific Advisory Board of CMTx-Biotech, a Long Island based company specializing in repurposing drugs, which is positioned to evaluate in clinical trials a modified tetracycline in the treatment of COVID-induced lung injury. He also continues to remain intricately involved with the implementation of global initiatives that ultimately impact a larger patient population.